Menu
In this new year, “new” is the operative word. Introducing our new name and medical director, new educational videos, new single scorecard and the new value-based contracts in our portfolio.
Read MoreDespite the challenges COVID-19 presents, our work continues. In this issue we answer your frequently asked questions about attribution and discuss ideas for optimizing medication therapies.
Read MoreFind information supporting many of our key endeavors for the year, chief among them our work to curb medical costs in three arenas: inpatient utilization, emergency department utilization and pharmacy.
Read MoreWith our focus on those cost drivers we can most readily influence, we offer Transitional Care FAQs and a Formulary Quick Reference Guide to help reduce pharmacy costs for patients and payers.
Read More